Board to consider Final Dividend
Nectar Lifesciences Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 30, 2016, inter alia, to consider and approve, amongst items:1. The Audited Financial Results for the Financial Year 2015-16, Financial Statement of the Company for the Financial Year 2015-16 and matters related thereto.... Shareholding for the Period Ended March 31, 2016
Nectar Lifesciences Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2016. For more details, kindly Click here Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended March 31, 2016
Nectar Lifesciences Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended March 31, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Financial Results, Limited Review Report for December 31, 2015
Nectar Lifesciences Ltd has informed BSE about : 1. Standalone Financial Results for the period ended December 31, 20152. Standalone Limited Review for the period ended December 31, 2015 Board Intimation for Results & Closure of Trading Window
Nectar Lifesciences Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on February 08, 2016, inter alia, to consider the Unaudited Financial Results of the Company for the period ended on December 31, 2015.Further, the trading window of the Company shall stand closed from February 01, 2016 i.e. 7 days prior to the declaration of the unaudited financial results for the period ended on December 31, 2015... Shareholding for the Period Ended December 31, 2015
Nectar Lifesciences Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2015. For more details, kindly Click here Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015
Nectar Lifesciences Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2015, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Appointment of Additional Independent Director
Nectar Lifesciences Ltd has informed BSE that the Board of Directors, through resolution by circulation passed on December 29, 2015, have appointed Ms. Guljit Chaudhri as an Additional Independent Director of the Company with effect from December 29, 2015. The above appointment shall also comply the requirement of appointment of Woman Director as per the provisions of Companies Act, 2013 and Listing Regulations. She will hold the office upto the... Nectar Lifesciences Ltd. honoured with NECA 2015 Award
Nectar Lifesciences Ltd has submitted to BSE a copy of Press Release dated December 16, 2015 titled "Nectar Lifesciences Ltd. honoured with NECA 2015 Award". Outcome of Board Meeting
Nectar Lifesciences Ltd has informed BSE that the Board of Directors of the Company at its meeting held on November 13, 2015, inter alia, have decided and approved :1. The following policies as per Listing Regulations:A. Policy on Preservation of DocumentsB. Policy on Materiality of an Event or Information for Making Disclosures to Stock Exchange(s). This policy is disclosed on the website of the Company....